The cellular uptake kinetics and acute biological effects of various oxovanadium species: A comparative study

Hormone and Metabolic Research

Volumn 30, Issue 1, 1998, Pages 29-33

  Reuland, D J ^a   Cao, Z X ^b   Rosenhein, L ^a   Poehlein, S ^a   McCoy, L ^a   Turner, J ^a   Durham, T ^a   Ganguli, S ^b  

^a INDIANA STATE UNIVERSITY   (United States)

^b Indiana University   (United States)

Author keywords

Cellular uptake; Insulin mimetics; Oxovanadium compounds

Indexed keywords

VANADIC ACID; VANADIUM DERIVATIVE; BISPEROXO(1,10 PHENANTHROLINE)OXOVANADATE(1 ); BISPEROXO(1,10-PHENANTHROLINE)OXOVANADATE(1-); ORGANOMETALLIC COMPOUND; PHENANTHROLINE DERIVATIVE; PHOSPHOPROTEIN; PHOSPHOTYROSINE;

ANIMAL CELL; ARTICLE; BIOAVAILABILITY; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG UPTAKE; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION; COMPARATIVE STUDY; KINETICS; METABOLISM; PHOSPHORYLATION;

ANIMALIA;

KINETICS; ORGANOMETALLIC COMPOUNDS; PHENANTHROLINES; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; TUMOR CELLS, CULTURED; VANADATES;

EID: 0031594657     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978826     Document Type: Article

References (16)

1. Willsky GR. In: Vanadium in biological systems. Chasten ND (ed.). Boston/London: Kluwer Academic Publisher. 1990: 1-25
2. Michibata H, Sakuri H. In: Vanadium in biological systems. Chasten ND (ed.). Boston/London: Kluwer Academic Publisher. 1990: 153-71
3. Nielson FH. In: Metal ion in biological system. Segal H, Segal A. (eds.). New York/Basel/Hong Kong: Marcel Dekker Inc. 1995: 543-65
4. Shechter YA, Shisheva R, Lazar J, Libman J, Shanzer A. Hydrophobic carriers of vanadyl ions augment the insulinomimetic effects of vanadyl ions in rat adipocytes. Biochemistry 1992: 31: 2063-73
5. Schwartz A, Adams RJ, Grupp I, Grupp G, Holroyde MJ. Effect of vanadate on myocardial function. Basic Res Cardiol 1980: 75: 444-51
6. Swarup G, Cohen S, Garber DL. Inhibition of membrane phosphotyrosyl protein phospatase activity by vanadate. Biochem Biophys Res Commun 1982; 107: 1104-9.
7. Posener BL, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS, Shaver A. Peroxovanadium compounds. J Biol Chem 1994; 269: 4596-604
8. Shechter Y. Insulin-mimetic effects of vanadate. Diabetes 1989; 39: 1-5
9. Lui J, Reuland DJ, Ganguli S. Differential effects of insulin and oxovanadiums on blood glucose and lactate metabolism. Metabolism 1997; 46: 562-72
10. Vuletic N, Djordjevic C. Oxoperoxovanadate (V) complexes with bidentate ligands. J Chem Soc Dalton Trans Issue 1973; 11: 1137-41
11. 2 lymphoma cell line. J Cell Physiol 1996; 167: 251-60
12. Laemmli UK. Cleavage of structural proteins during assembly of the head bacteriophage. Nature 1970; 227: 680-5
13. 2+-ATPase of sarcoplasmic reticulum from heart pig. Basic Res Cardiol 1980; 75: 452-4
14. Huyer G, Lui S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Greser MJ, Ramachandran C. Mechanism of inhibiton of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 197; 272: 843-51
15. Zhang M, Zhou M, Van Etten RL, Stauffacher CV. Crystal structure of bovine low molecular weight of phosphotyrosyl phosphatase complexed with the transition state analog vanadate. Biochemistry 1997; 36: 15-23
16. Tasiopoulos AJ, Vlahos AT, Keramidas AD, Kabanos TA, Deligiannakis YG, Raptopoulou CP, Terzis A. Models of oxovanadium (iv) protein interactions: the first oxovanadium (iv) complexes with dipeptides. Angew: Chem Int Ed Engl 1996; 35: 2531-2